Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study

Zemen Addis1,2, Yibeltal Aschale1, Abebe Fenta1

  • 1Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, Ethiopia.

PubMed
Abstract

Insights

Staphylococcus aureus infections were found in 11.2% of patients, with significant methicillin and inducible clindamycin resistance. Factors like illiteracy and low income were associated with S. aureus, highlighting the need for targeted interventions.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Staphylococcus aureus is a leading cause of global morbidity and mortality.
  • Antibiotic resistance in S. aureus complicates treatment.
  • Limited data exists on S. aureus prevalence and resistance patterns in Ethiopia.

Purpose of the Study:

  • To determine the prevalence of S. aureus infections.
  • To assess methicillin and inducible clindamycin resistance patterns.
  • To identify factors associated with S. aureus infection in Northwest Ethiopia.

Main Methods:

  • A hospital-based cross-sectional study was conducted.
  • S. aureus identification and antimicrobial susceptibility testing (disk diffusion, D-test) were performed.
  • Logistic regression analysis identified associated factors.

Main Results:

  • S. aureus was identified in 11.2% of participants.
  • Methicillin resistance was 36.9%, and inducible clindamycin resistance was 26.3%.
  • Illiteracy, larger family size, and low income were associated with S. aureus infection.

Conclusions:

  • A significant burden of S. aureus, methicillin, and inducible clindamycin resistance exists.
  • Routine D-test screening is crucial for guiding clindamycin therapy.
  • Targeted health education is needed for high-risk populations and rural areas.